Juan Alberto Nader-Kawachi

Dr. Juan Alberto Nader-Kawachi

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2003 in Cerebrovascular Diseases
Verified
Journal Article
Closed access
PDF file
WMWolfgang Müllges
Wolfgang Müllges
DFDorothea Franke
Dorothea Franke
WRWilko Reents
Wilko Reents
JBJörg Babin-Ebell
Jörg Babin-Ebell
KTKlaus V. Toyka
Klaus V. Toyka
IHIii John Huston
Iii John Huston
Edaravone, a novel free radical scavenger, demonstrates neuroprotective effects by inhibiting vascular endothelial cell injury and ameliorating neuronal damage in ischemic brain models. The present study was undertaken to verify its therapeutic efficacy following acute ischemic stroke. We performed a multicenter, randomized, placebo-controlled, double-blind study on acute ischemic stroke patients commencing within 72 h of onset. Edaravone was infused at a dose of 30 mg, twice a day, for 14 days. At discharge within 3 months or at 3 months after onset, the functional outcome was evaluated using the modified Rankin Scale. Two hundred and fifty-two patients were initially enrolled. Of these, 125 were allocated to the edaravone group and 125 to the placebo group for analysis. Two patients were excluded because of subarachnoid hemorrhage and disseminated intravascular coagulation. A significant improvement in functional outcome was observed in the edaravone group as evaluated by the modified Rankin Scale (p = 0.0382). Edaravone represents a neuroprotective agent which is potentially useful for treating acute ischemic stroke, since it can exert significant effects on functional outcome as compared with placebo.

1 September 1996 in Stroke
Verified
Journal Article
Closed access
PDF file
MOMaría del Mar SáeZ de Ocariz
María del Mar SáeZ de Ocariz
JNJuan Alberto Nader-Kawachi
Juan Alberto Nader-Kawachi
JSJosé A. Santos
José A. Santos
MBMiguel Bautista
Miguel Bautista
Background and Purpose The data of patients with an MRI-confirmed diagnosis of thalamic stroke were analyzed to identify risk factors and to describe the clinical syndromes according to the thalamic arterial territory involved. Methods We examined the records of all patients with a diagnosis of thalamic stroke confirmed by MRI who attended the National Institute of Neurology and Neurosurgery “Manuel Velasco Suárez” from 1987 through 1995. A database containing demographic features, risk factors, clinical course, type and mechanism of stroke, and vascular territory was analyzed. Results Twenty-eight patients (19 men and 9 women; mean age, 48.2 years) had MRI-confirmed thalamic stroke. Infarct was present in 22 patients and hemorrhage in 6. Eleven (39.3%) patients were younger than 45 years. In these young patients, cigarette smoking was the main risk factor associated with the development of stroke. In young patients, isolated and multiple thalamic lesions were present in almost equal proportions. The remaining 17 patients were older adults (45 to 84 years of age). In such patients, most lesions were multiple and were associated with atherosclerosis-predisposing factors. The main distinguishing clinical feature for hemorrhages and paramedian infarcts in comparison with infarcts in the other thalamic territories was the presence of an altered level of consciousness. No patient died as a direct result of the stroke. Conclusions Thalamic stroke commonly occurs in young adults, and its mechanism is often undetermined. Increased awareness of this type of stroke in young adults should lead to better delineation of its clinical features, course, and management.

1 March 2004 in Brain Research
Verified
Journal Article
Closed access
CRCamilo Ríos
Camilo Ríos
JNJuan Alberto Nader-Kawachi
Juan Alberto Nader-Kawachi
ARAna Julia Rodriguez-Payán
Ana Julia Rodriguez-Payán
CNConcepción Nava-Ruiz
Concepción Nava-Ruiz

14 July 2015 in Journal of Clinical Ultrasound
Verified
Journal Article
Closed access
PDF file
OBOscar H Del Brutto
Oscar H Del Brutto
RMRobertino M Mera
Robertino M Mera
MAMaría De La Luz Andrade
María De La Luz Andrade
VEVerónica Espinosa
Verónica Espinosa
PCPablo R Castillo
Pablo R Castillo
JNJuan Alberto Nader-Kawachi
Juan Alberto Nader-Kawachi

1 November 2018 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
Oscar H Del BruttoOscar H Del Brutto
Oscar H Del Brutto
RMRobertino M. Mera
Robertino M. Mera
VEVerónica Espinosa
Verónica Espinosa
JNJuan Alberto Nader-Kawachi
Juan Alberto Nader-Kawachi
MZMauricio Zambrano
Mauricio Zambrano
GMGautam Matcha
Gautam Matcha

1 March 2015 in Journal of Neurosciences in Rural Practice
Verified
Journal Article
Open access
PDF file
Oscar H Del BruttoOscar H Del Brutto
Oscar H Del Brutto
RMRobertino M. Mería
Robertino M. Mería
MAMaría de la Luz Andrade
María de la Luz Andrade
PCPablo R. Castillo
Pablo R. Castillo
MZMauricio Zambrano
Mauricio Zambrano
JNJuan Alberto Nader-Kawachi
Juan Alberto Nader-Kawachi
Background: Diagnosis of cerebral small vessel disease (SVD) is a challenge in remote areas where magnetic resonance imaging (MRI) is not available. Hospital-based studies in high-risk or stroke patients have found an association between the pulsatility index (PI) of intracranial arteries - as derived from transcranial Doppler (TCD) - and white matter hyperintensities (WMH) of presumed vascular origin. We aimed to assess the reliability of cerebral pulsatility indices to identify candidates for MRI screening in population-based studies assessing prevalence of SVD. Methods: A representative sample of stroke-free Atahualpa residents aged ≥65 years investigated with MRI underwent TCD. Using generalized linear models, we evaluated whether the PI of major intracranial arteries correlate with WMH (used as a proxy of diffuse SVD), after adjusting for demographics and cardiovascular risk factors. Results: Out of 70 participants (mean age 70.6 ± 4.6 years, 57% women), 28 (40%) had moderate-to-severe WMH. In multivariate models, there were no differences across categories of WMH in the mean PI of middle cerebral arteries (1.10 ± 0.16 vs. 1.22 ± 0.24, β: 0.065, 95% confidence interval (CI): −0.084-0.177, P = 0.474) or vertebrobasilar arteries (1.11 ± 0.16 vs. 1.29 ± 0.27, β: 0.066, 95% CI: −0.0024-0.156, P = 0.146). Conclusions: Cerebral PI should not be used to identify candidates for MRI screening in population-based studies assessing the burden of SVD.